-
A novel risk model for predicting early relapse in acute myeloid leukemia patients undergoing allogeneic hematopoietic stem-cell transplantation
Author: Yuan, Xiao-Lin; Lai, Xiao-Yu; Wu, Yi-Bo; Yang, Lu-Xin; Shi, Ji-Min; Liu, Li-Zhen; Yu, Jian; Zhao, Yan-Min; Zheng, Wei-Yan; He, Jing-Song; Sun, Jie; Wu, Wen-Jun; Zhao, Yi; Ye, Yi-Shan; Cai, Zhen; Huang, He; Luo, Yi
Journal: BONE MARROW TRANSPLANTATION. 2023; Vol. , Issue , pp. -. DOI: 10.1038/s41409-023-01979-5
-
Safety and efficacy of fecal microbiota transplantation in the treatment of graft-versus-host disease
Author: Qiao, Xiaoying; Bilinski, Jaroslaw; Wang, Leyi; Yang, Tianyu; Luo, Rongmu; Fu, Yi; Yang, Guibin
Journal: BONE MARROW TRANSPLANTATION. 2023; Vol. 58, Issue 1, pp. 10-19. DOI: 10.1038/s41409-022-01824-1
-
Predicting the loss of hepatitis B surface antigen following haematopoietic stem cell transplantation in patients with chronic HBV infection
Author: Sun, Xueyan; Fu, Haixia; Wang, Chencong; Zhang, Yuanyuan; Han, Wei; Chen, Huan; Wang, Yu; Chen, Qi; He, Yun; Huang, Qiusha; Yan, Chenhua; Chen, Yao; Han, Tingting; Lv, Meng; Mo, Xiaodong; Wang, Jingzhi; Wang, Fengrong; Chen, Yuhong; Zhu, Xiaolu; Xu, Lanping; Liu, Kaiyan; Huang, Xiaojun; Zhang, Xiaohui
Journal: BONE MARROW TRANSPLANTATION. 2023; Vol. 58, Issue 3, pp. 265-272. DOI: 10.1038/s41409-022-01880-7
-
Efficacy and safety of relmacabtagene autoleucel, an anti-CD19 chimeric antigen receptor T cell, in relapsed/refractory B-cell non-Hodgkin's lymphoma: 2-year results of a phase 1 trial
Author: Ying, Zhitao; Xie, Yan; Zheng, Wen; Liu, Weiping; Lin, Ningjing; Tu, Meifeng; Wang, Xiaopei; Ping, Lingyan; Deng, Lijuan; Zhang, Chen; Wu, Meng; Feng, Feier; Du, Tingting; Tang, Yongjing; Su, Fang; Guo, Ziyu; Li, James; Song, Yuqin; Zhu, Jun
Journal: BONE MARROW TRANSPLANTATION. 2023; Vol. 58, Issue 3, pp. 288-294. DOI: 10.1038/s41409-022-01888-z
-
Comparison of haploidentical hematopoietic stem cell transplantation with chemotherapy in older adults with acute myeloid leukemia
Author: Sun, Yu-Qian; Zhang, Xiao-Hui; Jiang, Qian; Jiang, Hao; Chang, Ying-Jun; Wang, Yu; Xu, Lan-Ping; Liu, Kai-Yan; Huang, Xiao-Jun
Journal: BONE MARROW TRANSPLANTATION. 2023; Vol. 58, Issue 5, pp. 491-497. DOI: 10.1038/s41409-023-01925-5
-
Prognostic factors and clinical outcomes in patients with relapsed acute leukemia after allogeneic hematopoietic stem cell transplantation
Author: Gao, Yang; Wu, Hengwei; Shi, Zhuoyue; Gao, Fei; Shi, Jimin; Luo, Yi; Yu, Jian; Lai, Xiaoyu; Fu, Huarui; Liu, Lizhen; Huang, He; Zhao, Yanmin
Journal: BONE MARROW TRANSPLANTATION. 2023; Vol. , Issue , pp. -. DOI: 10.1038/s41409-023-01989-3
-
Effects of donor-specific antibodies on engraftment and long-term survival after allogeneic hematopoietic stem cell transplantation-A systematic review and meta-analysis
Author: Huang, Yarui; Luo, Chengxin; Wu, Guixian; Huang, Xiangtao; Ding, Yaqun; Huang, Zhen; Chen, Jieping; Li, Xi; Xu, Shuangnian
Journal: BONE MARROW TRANSPLANTATION. 2023; Vol. 58, Issue 5, pp. 544-551. DOI: 10.1038/s41409-023-01932-6
-
Effects of post-transplant maintenance therapy with decitabine prophylaxis on the relapse for acute lymphoblastic leukemia
Author: Fan, Jixin; Lu, Runqing; Zhu, Jingkui; Guo, Xiao; Wan, Dingming; Xie, Xinsheng; Cao, Weijie; Zhang, Yinyin; Zhao, Haiqiu; Li, Yingmei; Guo, Rongqun; Jiang, Zhongxing; Song, Yongping; He, Fei; Guo, Rong
Journal: BONE MARROW TRANSPLANTATION. 2023; Vol. , Issue , pp. -. DOI: 10.1038/s41409-023-01948-y
